710 related articles for article (PubMed ID: 32273508)
1. Uveal melanoma.
Jager MJ; Shields CL; Cebulla CM; Abdel-Rahman MH; Grossniklaus HE; Stern MH; Carvajal RD; Belfort RN; Jia R; Shields JA; Damato BE
Nat Rev Dis Primers; 2020 Apr; 6(1):24. PubMed ID: 32273508
[TBL] [Abstract][Full Text] [Related]
2. Uveal melanoma: Recent advances in immunotherapy.
Sorrentino FS; De Rosa F; Di Terlizzi P; Toneatto G; Gabai A; Finocchio L; Salati C; Spadea L; Zeppieri M
World J Clin Oncol; 2024 Jan; 15(1):23-31. PubMed ID: 38292657
[TBL] [Abstract][Full Text] [Related]
3. Posterior uveal melanoma. The Swedish perspective.
Seregard S
Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
[TBL] [Abstract][Full Text] [Related]
4. [Uveal melanoma: current insights into clinical relevance of genetic testing].
Metz CH; Lohmann D; Zeschnigk M; Bornfeld N
Klin Monbl Augenheilkd; 2013 Jul; 230(7):686-91. PubMed ID: 23877823
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
6. Solitary Metastases Presentation from Uveal Melanoma: Report of 3 Cases and a Comprehensive Review of the Literature.
Pereira PM; Luís A; Passos MJ; Gouveia E
Ocul Oncol Pathol; 2023 Feb; 8(4-6):203-210. PubMed ID: 36925729
[TBL] [Abstract][Full Text] [Related]
7. Uveal melanoma: From diagnosis to treatment and the science in between.
Chattopadhyay C; Kim DW; Gombos DS; Oba J; Qin Y; Williams MD; Esmaeli B; Grimm EA; Wargo JA; Woodman SE; Patel SP
Cancer; 2016 Aug; 122(15):2299-312. PubMed ID: 26991400
[TBL] [Abstract][Full Text] [Related]
8. Current molecular and clinical insights into uveal melanoma (Review).
Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
[TBL] [Abstract][Full Text] [Related]
9. Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.
Damato B
Eye (Lond); 2012 Sep; 26(9):1157-72. PubMed ID: 22744385
[TBL] [Abstract][Full Text] [Related]
10. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
[TBL] [Abstract][Full Text] [Related]
11. Whole-genome copy-number analysis identifies new leads for chromosomal aberrations involved in the oncogenesis and metastastic behavior of uveal melanomas.
van Engen-van Grunsven AC; Baar MP; Pfundt R; Rijntjes J; Küsters-Vandevelde HV; Delbecq AL; Keunen JE; Klevering JB; Wesseling P; Blokx WA; Groenen PJ
Melanoma Res; 2015 Jun; 25(3):200-9. PubMed ID: 25756553
[TBL] [Abstract][Full Text] [Related]
12. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma: Current evidence on prognosis, treatment and potential developments.
Gelmi MC; Jager MJ
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100060. PubMed ID: 38641203
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in uveal melanoma.
Singh AD; Shields CL; Shields JA
Melanoma Res; 2001 Jun; 11(3):255-63. PubMed ID: 11468514
[TBL] [Abstract][Full Text] [Related]
15. Screening for uveal melanoma metastasis. Literature review.
Missotten GS; Keunen JE
Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915
[TBL] [Abstract][Full Text] [Related]
16. SOX10 Expression as Well as BRAF and GNAQ/11 Mutations Distinguish Pigmented Ciliary Epithelium Neoplasms From Uveal Melanomas.
Mori T; Sukeda A; Sekine S; Shibata S; Ryo E; Okano H; Suzuki S; Hiraoka N
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5445-5451. PubMed ID: 29059311
[TBL] [Abstract][Full Text] [Related]
17. Oncogene status as a diagnostic tool in ocular and cutaneous melanoma.
Griewank KG; Schilling B; Scholz SL; Metz CH; Livingstone E; Sucker A; Möller I; Reis H; Franklin C; Cosgarea I; Hillen U; Steuhl KP; Schadendorf D; Westekemper H; Zimmer L
Eur J Cancer; 2016 Apr; 57():112-7. PubMed ID: 26918736
[TBL] [Abstract][Full Text] [Related]
18. Development of new therapeutic options for the treatment of uveal melanoma.
Wang JZ; Lin V; Toumi E; Wang K; Zhu H; Conway RM; Madigan MC; Murray M; Cherepanoff S; Zhou F; Shu W
FEBS J; 2021 Nov; 288(21):6226-6249. PubMed ID: 33838075
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and management of uveal melanoma.
Yonekawa Y; Kim IK
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations.
Mudhar HS; Doherty R; Salawu A; Sisley K; Rennie IG
Br J Ophthalmol; 2013 Jul; 97(7):924-8. PubMed ID: 23685997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
